Pharmaceutical Ingredients

Tacrolimus is an immunosuppressive drug. It is used after allogeneic organ transplant to lower the risk of organ rejection and also as a topical medication in the treatment of T-cell-mediated diseases such as eczema and psoriasis.

Azathioprine is an immunosuppressive medication. It is used in rheumatoid arthritis, granulomatosis with polyangiitis, Crohn's disease, ulcerative colitis, systemic lupus erythematosus and in kidney transplants to prevent rejection. 

Mycophenolate mofetil, also known as MMF or CellCept, is a prodrug of mycophenolic acid and classified as a reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH). This drug is an immunosuppressant combined with drugs such as Cyclosporine and corticosteroids to prevent organ rejection after hepatic, renal and cardiac transplants.

Rapamycin, also known as sirolimus , is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection and treat a rare lung disease called lymphangioleiomyomatosis. It has immunosuppressant functions in humans and is especially useful in preventing the rejection of kidney transplants.